These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 14968806)
1. Society for neuroscience-33rd annual meeting. Hannan AJ IDrugs; 2004 Jan; 7(1):7-8. PubMed ID: 14968806 [No Abstract] [Full Text] [Related]
2. Society of neuroscience-33rd annual meeting: neurological disorders. Taylor DP IDrugs; 2004 Jan; 7(1):15-8. PubMed ID: 14968808 [No Abstract] [Full Text] [Related]
3. Society of neuroscience-33rd annual meeting: metabotropic glutamate receptors. Danysz W IDrugs; 2004 Jan; 7(1):9-14. PubMed ID: 14968807 [No Abstract] [Full Text] [Related]
4. Neuroprotection: promise and pitfalls in anti-inflammatory treatment of Alzheimer's disease. Memo M; Blandini F; Nappi G; Spano P Funct Neurol; 2002; 17(4):175-6. PubMed ID: 12675259 [No Abstract] [Full Text] [Related]
5. Society for Neuroscience--36th Annual Meeting: Therapeutic potential for analgesic and neuroprotective treatments. Sovran L IDrugs; 2006 Dec; 9(12):812-4. PubMed ID: 17139562 [No Abstract] [Full Text] [Related]
6. Neuroscience meeting draws crowds, gripes, loyalty. Helmuth L Science; 2000 Oct; 290(5492):698-9. PubMed ID: 11184193 [TBL] [Abstract][Full Text] [Related]
7. The Society for Neuroscience 1995 annual meeting. Hu RJ Mol Psychiatry; 1996 Mar; 1(1):18-20. PubMed ID: 9118310 [No Abstract] [Full Text] [Related]
8. The Society for Neuroscience 2009 meeting report, part 4. Landhuis E J Alzheimers Dis; 2010; 20(2):673-9. PubMed ID: 20164578 [No Abstract] [Full Text] [Related]
9. Focusing on beta-amyloid: report of the 35th Annual Meeting of the Society for Neuroscience. Sato C; Iwatsubo T Amyloid; 2006 Jun; 13(2):114-6. PubMed ID: 16911967 [No Abstract] [Full Text] [Related]
10. Society for Neuroscience meeting. Neuroscience society plans to leave New Orleans high and dry. Bhattacharjee Y Science; 2005 Nov; 310(5752):1260. PubMed ID: 16311307 [No Abstract] [Full Text] [Related]
11. Australian neuroscience in 2006--highlights from the scientific meeting. Doggrell SA Drug News Perspect; 2006 Jun; 19(5):300-6. PubMed ID: 16941052 [TBL] [Abstract][Full Text] [Related]
12. [Alzheimer's disease: are non-steroidal anti-inflammatory drugs effective?]. Peters O Dtsch Med Wochenschr; 2012 Dec; 137(50):2627. PubMed ID: 23225182 [No Abstract] [Full Text] [Related]
13. Neuroscience collaborations meeting report: the Israel Society for Neuroscience, and the Institute of Neurosciences, Mental Health and Addiction in Canada, first joint meeting, Sunday, Dec. 15, 2002, Eilat, Israel. Gozes I J Mol Neurosci; 2003; 21(1):55-6. PubMed ID: 14500995 [No Abstract] [Full Text] [Related]
14. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging. Petanceska S; Ryan L; Silverberg N; Buckholtz N Alzheimers Dement; 2009 Mar; 5(2):130-2. PubMed ID: 19328442 [No Abstract] [Full Text] [Related]
15. Conference Report: 182nd AAAS Annual Meeting, Washington DC, February 11-15, 2016. Sharma HS; Skaper SD; Sharma A CNS Neurol Disord Drug Targets; 2016; 15(5):526-8. PubMed ID: 27174671 [No Abstract] [Full Text] [Related]
16. Pharmaceutical treatment of cognitive disorders in Alzheimer's disease. Senin U; Cherubini A; Palumbo B; Mecocci P Funct Neurol; 1997; 12(3-4):211-2. PubMed ID: 9218980 [No Abstract] [Full Text] [Related]